A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Auteur principal: | |
---|---|
Autres auteurs: | |
Format: | Thèse |
Langue: | English |
Publié: |
Brac University
2024
|
Sujets: | |
Accès en ligne: | http://hdl.handle.net/10361/24298 |